CORC

在结果中检索

CORC

浏览/检索结果: 共25条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Sensitivity enhancement of potassium ion (K+) detection based on graphene field-effect transistors with surface plasma pretreatment 期刊论文
SENSORS AND ACTUATORS B-CHEMICAL, 2019, 卷号: 285, 页码: 333-340
作者:  Yuan, Qilong;  Wu, Sudong;  Ye, Chen;  Liu, Xiangqi;  Gao, Jingyao
收藏  |  浏览/下载：34/0  |  提交时间：2019/11/19
Dose modification and therapy interruption due to adverse events in treatment with anlotinib for refractory advanced NSCLC: Data from ALTER0303 会议论文
作者:  Zhang, L.;  Si, X.;  Wang, H.;  Zhang, X.;  Wang, M.
收藏  |  浏览/下载：6/0  |  提交时间：2019/11/19
Rapid determination and conversion study of 5-hydroxymethylfurfural and its derivatives in glucose injection 期刊论文
New Journal of Chemistry, 2018, 卷号: 42, 页码: 17725-17731
作者:  Wang, Cheng;  Hou, Yajing;  Lin, Yuanyuan;  Xie, Yitong;  Wei, Di
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/19
The Critical Properties of Dimethyl Carbonate (DMC) + Alkanes Mixtures 期刊论文
Kung Cheng Je Wu Li Hsueh Pao/Journal of Engineering Thermophysics, 2018, 卷号: 39, 页码: 1181-1185
作者:  He, Mao-Gang;  Wang, Cheng-Jie;  Xin, Nan;  Liu, Yang;  Liu, Xiang-Yang
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/19
Rapid determination and conversion study of 5-hydroxymethylfurfural and its derivatives in glucose injection 期刊论文
NEW JOURNAL OF CHEMISTRY, 2018, 卷号: 42, 页码: 17725-17731
作者:  Wang, Cheng;  Hou, Yajing;  Lin, Yuanyuan;  Xie, Yitong;  Wei, Di
收藏  |  浏览/下载：7/0  |  提交时间：2019/11/26
Management of Anlotinib-Related Adverse Events: Data From ALTER 0303 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: 13, 页码: S505-S506
作者:  Si, X.;  Zhang, L.;  Wang, H.;  Zhang, X.;  Wang, M.
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/26
The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: 13, 页码: S505-S505
作者:  Si, X.;  Zhang, L.;  Wang, H.;  Zhang, X.;  Wang, M.
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/26
Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head-A first multicentre, randomised, double-blind, placebo-controlled clinical trial 期刊论文
JOURNAL OF ORTHOPAEDIC TRANSLATION, 2018, 卷号: 12, 页码: 36-44
作者:  Li, Zi-Rong;  Cheng, Li-Ming;  Wang, Kun-Zheng;  Yang, Nan-Ping;  Yang, Shu-Hua
收藏  |  浏览/下载：5/0  |  提交时间：2019/11/26
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. 期刊论文
JAMA oncology, 2018, 卷号: 4, 页码: 1569-1575
作者:  Han Baohui;  Li Kai;  Wang Qiming;  Zhang Li;  Shi Jianhua
收藏  |  浏览/下载：5/0  |  提交时间：2019/11/26
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment 期刊论文
CANCER BIOLOGY & MEDICINE, 2018, 卷号: 15, 页码: 443-451
作者:  Wang, Jing;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：5/0  |  提交时间：2019/11/26

©版权所有 ©2017 CSpace - Powered by CSpace